Loading…

Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease

Abstract Objective The peak systolic velocity (PSV) of the inferior thyroid artery (ITA) is increased in untreated hyperthyroid patients with Graves' disease (GD). We investigated the clinical significance of the ITA-PSV and its determinants in hyperthyroid GD patients. Patients and methods ITA...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2007-09, Vol.61 (8), p.472-476
Main Authors: Nagasaki, Toshiki, Inaba, Masaaki, Kumeda, Yasuro, Fujiwara-Ueda, Misako, Hiura, Yoshikazu, Nishizawa, Yoshiki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433
cites cdi_FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433
container_end_page 476
container_issue 8
container_start_page 472
container_title Biomedicine & pharmacotherapy
container_volume 61
creator Nagasaki, Toshiki
Inaba, Masaaki
Kumeda, Yasuro
Fujiwara-Ueda, Misako
Hiura, Yoshikazu
Nishizawa, Yoshiki
description Abstract Objective The peak systolic velocity (PSV) of the inferior thyroid artery (ITA) is increased in untreated hyperthyroid patients with Graves' disease (GD). We investigated the clinical significance of the ITA-PSV and its determinants in hyperthyroid GD patients. Patients and methods ITA-PSV, together with thyroid volume, was measured by ultrasonography in untreated hyperthyroid GD patients ( n = 49) and healthy subjects ( n = 22). Established markers of GD activity such as TSH receptor antibody (TRAb), thyroid stimulating antibody (TSAb), vascular endothelial growth factor (VEGF) and immunoglobulin E (IgE) were simultaneously determined. Results ITA-PSV, thyroid volume, VEGF and IgE were significantly higher in hyperthyroid GD patients than in normal subjects. ITA-PSV in hyperthyroid GD patients was correlated positively with serum levels of FT3 , FT4 and IgE, smoking index and thyroid volume, and negatively with total, HDL- and LDL-cholesterols, but did not correlate significantly with age, triglyceride, TRAb, TSAb or VEGF. In stepwise regression analysis, ITA-PSV showed significant positive and negative associations with IgE and LDL-cholesterol, respectively, in hyperthyroid GD patients. In the pre-treatment hyperthyroid state, FT4 and ITA-PSV, but not IgE, were found to be significantly and positively associated with the maintenance dose of methimazole (MMI) required to keep serum TSH within normal range for at least 12 months. Conclusion These results suggest that ITA-PSV in untreated hyperthyroid GD patients may reflect GD activity and thus MMI sensitivity.
doi_str_mv 10.1016/j.biopha.2007.02.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68269267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0753332207000236</els_id><sourcerecordid>68269267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433</originalsourceid><addsrcrecordid>eNqFksGK1TAUhoMoznX0DUSy0lXrSdqm7UaQYZwRBlyMrkOanNpce5uapHeoax_clHsHwY2rQPj-P5wvh5DXDHIGTLzf551186ByDlDnwHMA_oTsWFtBJtLVU7KDuiqyouD8grwIYQ8AlSia5-SC1SUHxtiO_L633yfbW60mjdT1NA6rd9bQbnTO0H50D1QFqujs0Vgdnd-gA8bBHtQvNyINOAUb7dHGldqJLlP0qCIaOqwz-se6WUWLUwz0wcaB3nh1xPCOGhtQBXxJnvVqDPjqfF6Sb5-uv17dZndfbj5ffbzLdMmqmKlOc4a9qUpeg4G2qKBvSqWUMX1lGKiuqNqkhhtUgvetKCtdq67UTdu0ZVkUl-TtqXf27ueCIcqDDRrHUU3oliBFw0XLRZ3A8gRq70Lw2MvZp3n9KhnIzb7cy5N9udmXwGWyn2Jvzv1Ld0DzN3TWnYAPJwDTlEeLXgadtOik1qOO0jj7vxf-LdCjndLvjT9wxbB3i5-SQclkSAF5v23AtgBQwxYXxR-HqK-S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68269267</pqid></control><display><type>article</type><title>Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease</title><source>ScienceDirect Journals</source><creator>Nagasaki, Toshiki ; Inaba, Masaaki ; Kumeda, Yasuro ; Fujiwara-Ueda, Misako ; Hiura, Yoshikazu ; Nishizawa, Yoshiki</creator><creatorcontrib>Nagasaki, Toshiki ; Inaba, Masaaki ; Kumeda, Yasuro ; Fujiwara-Ueda, Misako ; Hiura, Yoshikazu ; Nishizawa, Yoshiki</creatorcontrib><description>Abstract Objective The peak systolic velocity (PSV) of the inferior thyroid artery (ITA) is increased in untreated hyperthyroid patients with Graves' disease (GD). We investigated the clinical significance of the ITA-PSV and its determinants in hyperthyroid GD patients. Patients and methods ITA-PSV, together with thyroid volume, was measured by ultrasonography in untreated hyperthyroid GD patients ( n = 49) and healthy subjects ( n = 22). Established markers of GD activity such as TSH receptor antibody (TRAb), thyroid stimulating antibody (TSAb), vascular endothelial growth factor (VEGF) and immunoglobulin E (IgE) were simultaneously determined. Results ITA-PSV, thyroid volume, VEGF and IgE were significantly higher in hyperthyroid GD patients than in normal subjects. ITA-PSV in hyperthyroid GD patients was correlated positively with serum levels of FT3 , FT4 and IgE, smoking index and thyroid volume, and negatively with total, HDL- and LDL-cholesterols, but did not correlate significantly with age, triglyceride, TRAb, TSAb or VEGF. In stepwise regression analysis, ITA-PSV showed significant positive and negative associations with IgE and LDL-cholesterol, respectively, in hyperthyroid GD patients. In the pre-treatment hyperthyroid state, FT4 and ITA-PSV, but not IgE, were found to be significantly and positively associated with the maintenance dose of methimazole (MMI) required to keep serum TSH within normal range for at least 12 months. Conclusion These results suggest that ITA-PSV in untreated hyperthyroid GD patients may reflect GD activity and thus MMI sensitivity.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2007.02.002</identifier><identifier>PMID: 17420111</identifier><language>eng</language><publisher>France: Elsevier SAS</publisher><subject>Adolescent ; Adult ; Aged ; Antithyroid Agents - therapeutic use ; Blood Flow Velocity ; Color Doppler measurement ; Female ; Graves Disease - diagnostic imaging ; Graves Disease - drug therapy ; Graves Disease - physiopathology ; Graves' disease ; Humans ; Hyperthyroidism ; Immunoglobulin E ; Immunoglobulin E - blood ; Immunoglobulins, Thyroid-Stimulating - blood ; Inferior thyroid artery ; Internal Medicine ; Male ; Medical Education ; Methimazole ; Methimazole - therapeutic use ; Middle Aged ; Predictive Value of Tests ; Receptors, Thyrotropin - immunology ; Regional Blood Flow ; Thyroid Gland - blood supply ; Thyroid Gland - diagnostic imaging ; Thyroid Gland - pathology ; Thyroxine - blood ; Triiodothyronine - blood ; Ultrasonography, Doppler ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2007-09, Vol.61 (8), p.472-476</ispartof><rights>Elsevier Masson SAS</rights><rights>2007 Elsevier Masson SAS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433</citedby><cites>FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17420111$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nagasaki, Toshiki</creatorcontrib><creatorcontrib>Inaba, Masaaki</creatorcontrib><creatorcontrib>Kumeda, Yasuro</creatorcontrib><creatorcontrib>Fujiwara-Ueda, Misako</creatorcontrib><creatorcontrib>Hiura, Yoshikazu</creatorcontrib><creatorcontrib>Nishizawa, Yoshiki</creatorcontrib><title>Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>Abstract Objective The peak systolic velocity (PSV) of the inferior thyroid artery (ITA) is increased in untreated hyperthyroid patients with Graves' disease (GD). We investigated the clinical significance of the ITA-PSV and its determinants in hyperthyroid GD patients. Patients and methods ITA-PSV, together with thyroid volume, was measured by ultrasonography in untreated hyperthyroid GD patients ( n = 49) and healthy subjects ( n = 22). Established markers of GD activity such as TSH receptor antibody (TRAb), thyroid stimulating antibody (TSAb), vascular endothelial growth factor (VEGF) and immunoglobulin E (IgE) were simultaneously determined. Results ITA-PSV, thyroid volume, VEGF and IgE were significantly higher in hyperthyroid GD patients than in normal subjects. ITA-PSV in hyperthyroid GD patients was correlated positively with serum levels of FT3 , FT4 and IgE, smoking index and thyroid volume, and negatively with total, HDL- and LDL-cholesterols, but did not correlate significantly with age, triglyceride, TRAb, TSAb or VEGF. In stepwise regression analysis, ITA-PSV showed significant positive and negative associations with IgE and LDL-cholesterol, respectively, in hyperthyroid GD patients. In the pre-treatment hyperthyroid state, FT4 and ITA-PSV, but not IgE, were found to be significantly and positively associated with the maintenance dose of methimazole (MMI) required to keep serum TSH within normal range for at least 12 months. Conclusion These results suggest that ITA-PSV in untreated hyperthyroid GD patients may reflect GD activity and thus MMI sensitivity.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antithyroid Agents - therapeutic use</subject><subject>Blood Flow Velocity</subject><subject>Color Doppler measurement</subject><subject>Female</subject><subject>Graves Disease - diagnostic imaging</subject><subject>Graves Disease - drug therapy</subject><subject>Graves Disease - physiopathology</subject><subject>Graves' disease</subject><subject>Humans</subject><subject>Hyperthyroidism</subject><subject>Immunoglobulin E</subject><subject>Immunoglobulin E - blood</subject><subject>Immunoglobulins, Thyroid-Stimulating - blood</subject><subject>Inferior thyroid artery</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical Education</subject><subject>Methimazole</subject><subject>Methimazole - therapeutic use</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Receptors, Thyrotropin - immunology</subject><subject>Regional Blood Flow</subject><subject>Thyroid Gland - blood supply</subject><subject>Thyroid Gland - diagnostic imaging</subject><subject>Thyroid Gland - pathology</subject><subject>Thyroxine - blood</subject><subject>Triiodothyronine - blood</subject><subject>Ultrasonography, Doppler</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFksGK1TAUhoMoznX0DUSy0lXrSdqm7UaQYZwRBlyMrkOanNpce5uapHeoax_clHsHwY2rQPj-P5wvh5DXDHIGTLzf551186ByDlDnwHMA_oTsWFtBJtLVU7KDuiqyouD8grwIYQ8AlSia5-SC1SUHxtiO_L633yfbW60mjdT1NA6rd9bQbnTO0H50D1QFqujs0Vgdnd-gA8bBHtQvNyINOAUb7dHGldqJLlP0qCIaOqwz-se6WUWLUwz0wcaB3nh1xPCOGhtQBXxJnvVqDPjqfF6Sb5-uv17dZndfbj5ffbzLdMmqmKlOc4a9qUpeg4G2qKBvSqWUMX1lGKiuqNqkhhtUgvetKCtdq67UTdu0ZVkUl-TtqXf27ueCIcqDDRrHUU3oliBFw0XLRZ3A8gRq70Lw2MvZp3n9KhnIzb7cy5N9udmXwGWyn2Jvzv1Ld0DzN3TWnYAPJwDTlEeLXgadtOik1qOO0jj7vxf-LdCjndLvjT9wxbB3i5-SQclkSAF5v23AtgBQwxYXxR-HqK-S</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>Nagasaki, Toshiki</creator><creator>Inaba, Masaaki</creator><creator>Kumeda, Yasuro</creator><creator>Fujiwara-Ueda, Misako</creator><creator>Hiura, Yoshikazu</creator><creator>Nishizawa, Yoshiki</creator><general>Elsevier SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease</title><author>Nagasaki, Toshiki ; Inaba, Masaaki ; Kumeda, Yasuro ; Fujiwara-Ueda, Misako ; Hiura, Yoshikazu ; Nishizawa, Yoshiki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antithyroid Agents - therapeutic use</topic><topic>Blood Flow Velocity</topic><topic>Color Doppler measurement</topic><topic>Female</topic><topic>Graves Disease - diagnostic imaging</topic><topic>Graves Disease - drug therapy</topic><topic>Graves Disease - physiopathology</topic><topic>Graves' disease</topic><topic>Humans</topic><topic>Hyperthyroidism</topic><topic>Immunoglobulin E</topic><topic>Immunoglobulin E - blood</topic><topic>Immunoglobulins, Thyroid-Stimulating - blood</topic><topic>Inferior thyroid artery</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical Education</topic><topic>Methimazole</topic><topic>Methimazole - therapeutic use</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Receptors, Thyrotropin - immunology</topic><topic>Regional Blood Flow</topic><topic>Thyroid Gland - blood supply</topic><topic>Thyroid Gland - diagnostic imaging</topic><topic>Thyroid Gland - pathology</topic><topic>Thyroxine - blood</topic><topic>Triiodothyronine - blood</topic><topic>Ultrasonography, Doppler</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nagasaki, Toshiki</creatorcontrib><creatorcontrib>Inaba, Masaaki</creatorcontrib><creatorcontrib>Kumeda, Yasuro</creatorcontrib><creatorcontrib>Fujiwara-Ueda, Misako</creatorcontrib><creatorcontrib>Hiura, Yoshikazu</creatorcontrib><creatorcontrib>Nishizawa, Yoshiki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nagasaki, Toshiki</au><au>Inaba, Masaaki</au><au>Kumeda, Yasuro</au><au>Fujiwara-Ueda, Misako</au><au>Hiura, Yoshikazu</au><au>Nishizawa, Yoshiki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>61</volume><issue>8</issue><spage>472</spage><epage>476</epage><pages>472-476</pages><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Abstract Objective The peak systolic velocity (PSV) of the inferior thyroid artery (ITA) is increased in untreated hyperthyroid patients with Graves' disease (GD). We investigated the clinical significance of the ITA-PSV and its determinants in hyperthyroid GD patients. Patients and methods ITA-PSV, together with thyroid volume, was measured by ultrasonography in untreated hyperthyroid GD patients ( n = 49) and healthy subjects ( n = 22). Established markers of GD activity such as TSH receptor antibody (TRAb), thyroid stimulating antibody (TSAb), vascular endothelial growth factor (VEGF) and immunoglobulin E (IgE) were simultaneously determined. Results ITA-PSV, thyroid volume, VEGF and IgE were significantly higher in hyperthyroid GD patients than in normal subjects. ITA-PSV in hyperthyroid GD patients was correlated positively with serum levels of FT3 , FT4 and IgE, smoking index and thyroid volume, and negatively with total, HDL- and LDL-cholesterols, but did not correlate significantly with age, triglyceride, TRAb, TSAb or VEGF. In stepwise regression analysis, ITA-PSV showed significant positive and negative associations with IgE and LDL-cholesterol, respectively, in hyperthyroid GD patients. In the pre-treatment hyperthyroid state, FT4 and ITA-PSV, but not IgE, were found to be significantly and positively associated with the maintenance dose of methimazole (MMI) required to keep serum TSH within normal range for at least 12 months. Conclusion These results suggest that ITA-PSV in untreated hyperthyroid GD patients may reflect GD activity and thus MMI sensitivity.</abstract><cop>France</cop><pub>Elsevier SAS</pub><pmid>17420111</pmid><doi>10.1016/j.biopha.2007.02.002</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2007-09, Vol.61 (8), p.472-476
issn 0753-3322
1950-6007
language eng
recordid cdi_proquest_miscellaneous_68269267
source ScienceDirect Journals
subjects Adolescent
Adult
Aged
Antithyroid Agents - therapeutic use
Blood Flow Velocity
Color Doppler measurement
Female
Graves Disease - diagnostic imaging
Graves Disease - drug therapy
Graves Disease - physiopathology
Graves' disease
Humans
Hyperthyroidism
Immunoglobulin E
Immunoglobulin E - blood
Immunoglobulins, Thyroid-Stimulating - blood
Inferior thyroid artery
Internal Medicine
Male
Medical Education
Methimazole
Methimazole - therapeutic use
Middle Aged
Predictive Value of Tests
Receptors, Thyrotropin - immunology
Regional Blood Flow
Thyroid Gland - blood supply
Thyroid Gland - diagnostic imaging
Thyroid Gland - pathology
Thyroxine - blood
Triiodothyronine - blood
Ultrasonography, Doppler
Vascular Endothelial Growth Factor A - blood
title Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T17%3A29%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Significance%20of%20thyroid%20blood%20flow%20as%20a%20predictor%20of%20methimazole%20sensitivity%20in%20untreated%20hyperthyroid%20patients%20with%20Graves'%20disease&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Nagasaki,%20Toshiki&rft.date=2007-09-01&rft.volume=61&rft.issue=8&rft.spage=472&rft.epage=476&rft.pages=472-476&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2007.02.002&rft_dat=%3Cproquest_cross%3E68269267%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-abc21efd54270d09350f84aaaddf5d10ab3590162dea62f9645c7ab4c89894433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68269267&rft_id=info:pmid/17420111&rfr_iscdi=true